| Collaborations |
|
Schering AG
A strategic collaboration to develop and commercialize cardiovascular gene therapy products to promote angiogenesis. GENERXTM is being evaluated in Phase 2b/3 clinical trials for stable angina. GENVASCOR™ is being evaluated in Phase 1/2 clinical trials for peripheral vascular disease.
|
|
AmpliPhi Biosciences
Vector-licensing agreement for the potential treatment of congestive heart failure.
|